Supriya Lifescience Ltd. raises Rs 315 crore from anchor investors ahead of its IPO.
- ByStartupStory | December 16, 2021
Manufacturers and suppliers of active pharmaceutical ingredients, Supriya lifescience Ltd said that it has raised an amount of Rs 315 crore from anchor investors just ahead of its IPO. BNP Paribas Arbitrage, Societe Generale, Reliance General Insurance Company, Aditya Birla Sun Life Insurance Company, Kuber India Fund, Saint Capital Fund, Dovetail India Fund, Cohesion MK Best Ideas Sub-Trust, Malabar India Fund, and Nippon Life India Trustee Ltd are among the anchor investors.
The company said in a statement, “Trading Members of the Exchange are hereby informed that under the Anchor Investors (AIs) portion in the Public Issue of Supriya Lifescience Limited, 1,14,96,351 equity shares have been subscribed today at ₹274/- per equity share” Out of the total allocation of 1,14,96,351 shares to the anchor investors, 20,07,342 shares i.e 17.46 per cent of total allocation was allocated to Nippon Life India Trustee Ltd.
Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceutical ingredients (APIs), with a focus on research and development. Its IPO is set to open for bidding on December 16, 2021. The three-day IPO will conclude on December 20.
Follow Startup Story
Related Posts
